196 related articles for article (PubMed ID: 6315339)
1. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
Kuribayashi T; Tanaka H; Abe E; Suda T
Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339
[TBL] [Abstract][Full Text] [Related]
2. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells.
Shiina Y; Abe E; Miyaura C; Tanaka H; Yamada S; Ohmori M; Nakayama K; Takayama H; Matsunaga I; Nishii Y; DeLuca HF; Suda T
Arch Biochem Biophys; 1983 Jan; 220(1):90-4. PubMed ID: 6572492
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60).
Tanaka H; Abe E; Miyaura C; Kuribayashi T; Konno K; Nishii Y; Suda T
Biochem J; 1982 Jun; 204(3):713-9. PubMed ID: 6289803
[TBL] [Abstract][Full Text] [Related]
5. Cooperative effect of 1 alpha,25-dihydroxyvitamin D3 and dexamethasone in inducing differentiation of mouse myeloid leukemia cells.
Miyaura C; Abe E; Honma Y; Hozumi M; Nishii Y; Suda T
Arch Biochem Biophys; 1983 Dec; 227(2):379-85. PubMed ID: 6582801
[TBL] [Abstract][Full Text] [Related]
6. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells.
Freake HC; Iwasaki J; McCarthy DM
Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655
[TBL] [Abstract][Full Text] [Related]
7. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
8. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
9. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.
Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P
Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
11. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR
J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol.
Olsson I; Gullberg U; Ivhed I; Nilsson K
Cancer Res; 1983 Dec; 43(12 Pt 1):5862-7. PubMed ID: 6315218
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells.
Costa EM; Blau HM; Feldman D
Endocrinology; 1986 Nov; 119(5):2214-20. PubMed ID: 3021437
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
Abe J; Moriya Y; Saito M; Sugawara Y; Suda T; Nishii Y
Cancer Res; 1986 Dec; 46(12 Pt 1):6316-21. PubMed ID: 3490908
[TBL] [Abstract][Full Text] [Related]
17. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
18. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
20. Human colon cell line HT-29: characterisation of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone.
Brehier A; Thomasset M
J Steroid Biochem; 1988 Feb; 29(2):265-70. PubMed ID: 2831436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
